NC
CDNA icon

nVerses Capital’s CareDx CDNA Stock Holding History

nVerses Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,350
Closed -$301K – 327
2026
Q1 		$301K Buy
+17,350
New +$328K 0.27% 152
2024
Q4 		– Sell
-3,300
Closed -$103K – 154
2024
Q3 		$103K Buy
3,300
+2,100
+175% +$52.3K 0.05% 475
2024
Q2 		$18.6K Buy
+1,200
New +$14.5K 0.01% 809

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $159M AUM 139.66% 1-Year Est. Return

nVerses Capital's CDNA Position: Q2 2026 in Review

nVerses Capital sold out of CareDx (CDNA) in Q2 2026, closing a stake of 17,350 shares — an estimated $301K sold.

nVerses Capital first reported a position in CDNA in Q2 2024 and held it in 3 quarters. The position peaked at $301K in Q1 2026. 159 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • nVerses Capital reported no remaining CareDx position as of Q2 2026 after selling out during the quarter.
  • nVerses Capital sold 17,350 CareDx shares in Q2 2026, an estimated $301K.
  • nVerses Capital first reported a position in CareDx in Q2 2024 and held it in 3 quarters.
  • nVerses Capital's CareDx position peaked at $301K in Q1 2026.
  • 159 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.